Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network
Published November 16, 2016 · Recall initiated: September 19, 2016
Summary
FDA records drug Class II recall D-0126-2017, published November 16, 2016 and initiated September 19, 2016. Recalling firm: Wells Pharmacy Network, LLC; Status: Terminated; Reported quantity: 690 pellets; Lot: BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent and Subpotent drugs
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Wells Pharmacy Network, LLC
- Distributor
- U.S.
- Lot
- BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATestosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATestosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDAEstradiol 12.5 mg Pellet, Compounded by: Wells Pharmacy NetworkNovember 16, 2016
- FDATANDEM (TM) INTL COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71324038, 71324039, 71324040, 71324041,November 9, 2016
- FDATANDEM (TM) COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71322040, 71322041, 71322042, 71322043, 71322044,November 9, 2016
Questions about this recall
Was Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network recalled?
Yes. FDA published recall D-0126-2017 on November 16, 2016. Reported hazard: Superpotent and Subpotent drugs
What should I do if I have this product?
Voluntary: Firm initiated · Telephone